Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
about
Phosphodiesterase 5 inhibition ameliorates angiontensin II-induced podocyte dysmotility via the protein kinase G-mediated downregulation of TRPC6 activity.Sustained hyperosmolarity increses TGF-ß1 and Egr-1 expression in the rat renal medullaThe effects of vardenafil and pentoxifylline administration in an animal model of ischemic colitis.Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in PodocytesOxidative/Nitrative Stress and Inflammation Drive Progression of Doxorubicin-Induced Renal Fibrosis in Rats as Revealed by Comparing a Normal and a Fibrosis-Resistant Rat Strain.The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitusCinaciguat prevents the development of pathologic hypertrophy in a rat model of left ventricular pressure overload.Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.Phosphodiesterase type 5 inhibitors and kidney disease.An evaluation of vardenafil as a calcium channel blocker in pulmonary artery in ratsHydrogen Sulfide in Renal Physiology and Disease.The role of cGMP and its signaling pathways in kidney disease.Cinaciguat ameliorates glomerular damage by reducing ERK1/2 activity and TGF-ß expression in type-1 diabetic ratsPhosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7.Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy.Vardenafil ameliorates immunologic- and non-immunologic-induced allergic reactions.Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells.
P2860
Q33764566-5AA493F8-D034-46C3-BC96-A3343A2A540CQ33869077-D700CFD6-4088-4325-A471-59F937286CF2Q34628796-A032E78A-5BF6-436C-8D96-6188B5B1400BQ35583071-949C2B3F-7ED3-44BA-A1B6-43C447C9A637Q35666941-68E03E5A-FB91-4ECE-A38F-3C8B94D20AB3Q36234790-DC1B97C6-8CDC-45FC-83A6-AE9D7BDC9731Q37419185-5240C41B-BBA3-4AF7-83C7-1EDB9359A345Q37728038-31721FE0-F7B0-4C69-8BB7-0D2652CA21C3Q38560737-3B59B578-49EB-4737-ABDA-EFB8B5322A4FQ38760600-60789A97-C0D1-4F94-A9D6-AF1657FCCB59Q38785627-910B3006-9E20-4F80-ABEA-BC3322E03F52Q38896087-170CE65E-060C-46CC-8840-EA9FCEEE2D22Q41330819-5F603577-BD14-4A08-BB1D-7C3CED31C4DEQ42125804-213A1F78-4A1A-49A6-ADE8-2750507D0655Q42722900-77DF2B7D-A581-4703-9341-3832CA11C064Q44297447-DDEF98DF-D54F-4224-A7C1-79E68636C3B5Q46419349-4D28083F-8240-4AC8-B229-F8DA7F53D5D7
P2860
Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Selective phosphodiesterase-5 ...... ate (cGMP) level in podocytes.
@en
Selective phosphodiesterase-5 ...... ate (cGMP) level in podocytes.
@nl
type
label
Selective phosphodiesterase-5 ...... ate (cGMP) level in podocytes.
@en
Selective phosphodiesterase-5 ...... ate (cGMP) level in podocytes.
@nl
prefLabel
Selective phosphodiesterase-5 ...... ate (cGMP) level in podocytes.
@en
Selective phosphodiesterase-5 ...... ate (cGMP) level in podocytes.
@nl
P2093
P2860
P356
P1476
Selective phosphodiesterase-5 ...... hate (cGMP) level in podocytes
@en
P2093
Gábor Szabó
Lilla Fang
László Rosivall
Miklós M Mózes
Tamás Radovits
P2860
P304
P356
10.1093/NDT/GFS391
P407
P50
P577
2012-11-29T00:00:00Z